← vista completa

Published on February 1, 2009 | http://doi.org/10.5867/medwave.2009.02.3771

Hormone replacement therapy at low doses and prevention of osteoporosis

Terapia hormonal de reemplazo en dosis bajas y prevención de la osteoporosis

Wellington Aguirre

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Wellington Aguirre

Facultad de Ciencias Medicas, Universidad Central del Ecuador, Quito, Ecuador

Figures

Article has no figures.

Forum

No messages

History

Citation Aguirre W. Hormone replacement therapy at low doses and prevention of osteoporosis. Medwave 2009;9(02):e3771 doi: 10.5867/medwave.2009.02.3771

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/02/2009

Index

Metrics

Not available at the moment.

Notes

References

  1. Birdwood GB. Understanding Osteoporosis and Its Treatment. Carnforth, UK: Parthenon Publishing 1996:17.
  2. Bjarnason NH, Hassager C, Christiansen C. Postmenopausal bone remodelling and hormone replacement. Climacteric. 1998 Mar;1(1):72-9. | CrossRef | PubMed
  3. Lindsay R. The menopause sex steroids and osteoporosis. Clin Obstet Gynecol. 1987 Dec;30(4):847-59. | CrossRef | PubMed
  4. Christiansen MS et al. Dose response evaluation of cyclic estrogen /gestagen in postmenopausal women. Am J Obstet Gynecol. 1982 Dec 15;144(8):873-9. | PubMed
  5. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol. 1984 Jun;63(6):759-63. | PubMed
  6. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987 Jan;106(1):40-5. | PubMed
  7. Mizunuma H, Okano H, Soda M, Kagami I, Miyamoto S, Tokizawa T, et al. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy. Maturitas. 1997 May;27(1):69-76. | CrossRef | PubMed
  8. Recker RR, Davies KM, Dowd RM, Heaney RP. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: a randomized, controlled trial. Ann Intern Med. 1999 Jun 1;130(11):897-904. | PubMed
  9. McKeever C. Post menopausal bone loos is prevented by treatment with low dosage estrogen with calcium. Clin Ther 2000;22:845-57. | CrossRef
  10. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogen with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002 May 22-29;287(20):2668-76. | CrossRef | PubMed
  11. Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004 Sep;104(3):443-51. | CrossRef | PubMed
  12. Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas. 2008 Jan 20;59(1):2-6. Epub 2007 Dec 3. | CrossRef | PubMed
  13. Warming L, Ravn P, Spielman D, Delmas P, Christiansen C. Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause. 2004 May-Jun;11(3):337-42. | CrossRef | PubMed
  14. Banks E, Beral V, Reeves G, Balkwill A, Barnes I; Million Women Study Collaborators. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA. 2004 May 12;291(18):2212-20. | CrossRef | PubMed